[Uncomplicated urinary tract infections: preserving first-line antimicrobial agents in the updated guidelines]

Area of Science:

• Infectious Diseases
• Public Health
• Pharmacology

Background:

• Antimicrobial resistance (AMR) presents a significant global health and economic challenge.
• Uncomplicated urinary tract infections (UTIs) require ongoing monitoring for AMR, despite stable treatment guidelines.
• No new oral antibiotics have been approved, leading to continued reliance on existing agents.

Purpose of the Study:

• To evaluate fosfomycin as a safe and effective treatment option for uncomplicated UTIs in women.
• To emphasize the importance of regional antimicrobial resistance surveillance for guiding empirical antibiotic therapy.

Main Methods:

• Review of clinical guidelines and existing literature on UTI treatment.
• Assessment of fosfomycin's safety and efficacy compared to other antibiotics for uncomplicated UTIs.

Main Results:

• Single-dose fosfomycin demonstrates comparable safety and efficacy to other antibiotics for uncomplicated UTIs in women.
• Current clinical guidelines have not revised first-line antibiotic recommendations due to a lack of new oral agents.

Conclusions:

• Fosfomycin is a suitable empirical treatment choice for uncomplicated UTIs.
• Continuous surveillance of regional antimicrobial resistance patterns is essential for optimizing empirical antibiotic selection and combating AMR.